Patents by Inventor Anthony C. Forster

Anthony C. Forster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6977150
    Abstract: The present invention is a simplified, highly-purified, processive translation system that does not require the addition of translation factors EF-P, W, W2 or rescue. A new translation process offers new, potentially improved, routes to all peptides, proteins and peptidomimetics currently synthesized by alternative routes.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: December 20, 2005
    Inventors: Anthony C. Forster, Stephen C. Blacklow
  • Publication number: 20040091955
    Abstract: The present invention is a simplified, highly-purified, processive translation system that does not require the addition of translation factors EF-P, W, W2 or rescue. A new translation process offers new, potentially improved, routes to all peptides, proteins and peptidomimetics currently synthesized by alternative routes.
    Type: Application
    Filed: January 25, 2002
    Publication date: May 13, 2004
    Inventors: Anthony C. Forster, Stephen C. Blacklow
  • Patent number: 5168053
    Abstract: It has been discovered that it is possible to target any RNA molecule for cleavage by RNase P by forming a hybrid region consisting of a short sequence of base pairs followed by a terminal 3'- NCCA sequence. In the preferred embodiment, the region is formed by addition of an external guide sequence consisting of a nucleotide sequence complementary to the targeted site which includes a 3'-NCCA, wherein the sequence hybridizes to the targeted RNA to form a short sequence of double-stranded RNA under conditions promoting cleavage of the substrate at the nucleotide at the 5' side of the base-paired region by the RNase P or catalytically active equivalent thereof. Specificity is determined by the complementary sequence. The sequence is preferably ten to fifteen nucleotides in length and may contain non-complementary nucleotides to the extent this does not interfere with formation of several base pairs followed by a NCCA at the 3' end.
    Type: Grant
    Filed: August 17, 1990
    Date of Patent: December 1, 1992
    Assignee: Yale University
    Inventors: Sidney Altman, Anthony C. Forster, Cecilia L. Guerrier-Takada